Bilateral ovarian cancer with; capsule breached; ascites positive for malignant cells. Stage is;

## **Core Concept**
The question tests understanding of the FIGO (International Federation of Gynecology and Obstetrics) staging system for ovarian cancer, which is crucial for determining prognosis and treatment. Ovarian cancer staging is based on the extent of tumor spread.

## **Why the Correct Answer is Right**
The FIGO staging system for ovarian cancer is as follows: Stage I - tumor limited to ovaries; Stage II - tumor involves one or both ovaries with pelvic extension; Stage III - tumor involves one or both ovaries with cytologically or histologically confirmed peritoneal implants outside the pelvis and/or regional lymph node metastasis; Stage IV - distant metastasis. Given that the ovarian cancer is bilateral, the capsule is breached, and ascites is positive for malignant cells, this scenario describes a tumor that involves both ovaries with malignant cells in the ascites, indicating spread beyond the pelvis but not specifying distant metastasis. This scenario best fits **Stage III** according to the FIGO classification, particularly IIIA (microscopic peritoneal metastasis outside pelvis) or more likely IIIB (macroscopic peritoneal metastasis outside pelvis 2 cm or less in greatest dimension), given the breach of the capsule and positive ascites.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because Stage I implies the tumor is limited to the ovaries, which does not match the given scenario of bilateral ovarian cancer with capsule breached and malignant ascites.
- **Option B:** This option is incorrect as it suggests a stage that does not accurately reflect the extent of disease described; if it were Stage II, it would imply pelvic extension without specifying distant or peritoneal spread beyond the pelvis.
- **Option D:** This option is incorrect because Stage IV indicates distant metastasis, which is not specified in the scenario provided; the focus is on peritoneal and possibly regional spread rather than distant sites.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the FIGO staging for ovarian cancer is primarily based on surgical findings and pathological examination. The presence of malignant cells in ascites or peritoneal washings is a critical factor for upstaging to Stage III.

## **Correct Answer:** .